Literature DB >> 18290876

Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease.

Julie R McMullen1.   

Abstract

1. The insulin-like growth factor 1 (IGF1)-phosphoinositide 3-kinase (PI3-K) pathway is a critical regulator of cell and organ growth. 2. In the heart, the IGF1-PI3-K pathway induces physiological heart growth with preserved or enhanced cardiac function. 3. The present review specifically discusses the role of the IGF1-PI3-K pathway in the setting of heart disease. 4. Genetic mouse models have highlighted the beneficial effects of the IGF1-PI3-K pathway in the heart in a setting of disease. These include maintenance of contractile function, antifibrotic and anti-apoptotic actions, inhibition of signalling transducers activated in disease settings and regeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18290876     DOI: 10.1111/j.1440-1681.2007.04873.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  12 in total

1.  Phosphoinositide 3-kinase (PI3K(p110alpha)) directly regulates key components of the Z-disc and cardiac structure.

Authors:  Ashley J Waardenberg; Bianca C Bernardo; Dominic C H Ng; Peter R Shepherd; Nelly Cemerlang; Mauro Sbroggiò; Christine A Wells; Brian P Dalrymple; Mara Brancaccio; Ruby C Y Lin; Julie R McMullen
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

2.  Fetal growth restriction and the programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb.

Authors:  Kimberley C W Wang; Lei Zhang; I Caroline McMillen; Kimberley J Botting; Jaime A Duffield; Song Zhang; Catherine M Suter; Doug A Brooks; Janna L Morrison
Journal:  J Physiol       Date:  2011-08-01       Impact factor: 5.182

Review 3.  Importance of myocyte-nonmyocyte interactions in cardiac development and disease.

Authors:  Ying Tian; Edward E Morrisey
Journal:  Circ Res       Date:  2012-03-30       Impact factor: 17.367

Review 4.  Recent advances of adapter proteins in the regulation of heart diseases.

Authors:  Li Tao; Linna Jia; Yuntian Li; Chengyun Song; Zheng Chen
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

5.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

6.  Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial.

Authors:  Rosa Collell; Ricardo Closa-Monasterolo; Natalia Ferré; Veronica Luque; Berthold Koletzko; Veit Grote; Roman Janas; Elvira Verduci; Joaquín Escribano
Journal:  Pediatr Res       Date:  2016-02-16       Impact factor: 3.756

7.  Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload.

Authors:  Norifumi Takeda; Ichiro Manabe; Yuichi Uchino; Kosei Eguchi; Sahohime Matsumoto; Satoshi Nishimura; Takayuki Shindo; Motoaki Sano; Kinya Otsu; Paige Snider; Simon J Conway; Ryozo Nagai
Journal:  J Clin Invest       Date:  2009-12-21       Impact factor: 14.808

8.  Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling.

Authors:  Norifumi Takeda; Ichiro Manabe
Journal:  Int J Inflam       Date:  2011-09-18

9.  Mesenchymal-endothelial transition-derived cells as a potential new regulatory target for cardiac hypertrophy.

Authors:  Wenyan Dong; Ruiqi Li; Haili Yang; Yan Lu; Longhai Zhou; Lei Sun; Dianliang Wang; Jinzhu Duan
Journal:  Sci Rep       Date:  2020-04-20       Impact factor: 4.379

Review 10.  The intercalated disc: a mechanosensing signalling node in cardiomyopathy.

Authors:  Mihai Pruna; Elisabeth Ehler
Journal:  Biophys Rev       Date:  2020-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.